IRVINE, Calif., May 9 Saint Barnabas MedicalCenter and Masimo, the inventor of Pulse CO-Oximetry andMeasure-Through-Motion-and-Low-Perfusion Pulse Oximetry, have announced thecompletion of Saint Barnabas Medical Center's hospital-wide implementation ofMasimo SET pulse oximetry. The New Jersey-based hospital performed anextensive comparison and thorough evaluation spanning virtually everydepartment and cited superior performance, technology capabilities and futureclinical application as chief reasons for converting to Masimo SET.
"The decision to convert to Masimo SET pulse oximetry was multifaceted,with numerous benefits that we didn't think were possible in one technology,"said Shyan Sun, M.D., Director of Neonatology, Saint Barnabas Medical Center."With Masimo, we now have a standardized technology for oximetry that not onlyenables sensor consistency and standardization across departments at reducedcosts, but also provides the system compatibility necessary to track oximetryinventory and costs -- all in a technology platform that is uniquelyexpandable to support our current and future oximetry needs."
Saint Barnabas Medical Center is the flagship of the Saint Barnabas HealthCare System, New Jersey's largest integrated health care delivery system, andranks among the top 5 percent of all hospitals in the country. The 601-bedinstitution treats more patients annually and delivers more babies than anyother facility in New Jersey, including more than 40,000 inpatients admissions,over 65,000 Emergency Department visits, and nearly 7,000 births each year.Additionally, the Medical Center and its Ambulatory Care Center providetreatment and services for more than 300,000 outpatient visits annually. TheSaint Barnabas Health Care System includes six acute care hospitals, abehavioral health center, ambulatory care facilities, eight nursing andrehabilitation centers, an assisted living facility, geriatric centers, astate-wide behavioral health network, and comprehensive home care and hospiceprograms.
Prior to their conversion, Saint Barnabas had a handful of variousoximetry monitors and technologies that each required different sensors fromdifferent vendors -- eliminating the ability to purchase sensors in combinedvolume. On top of this, these varying technologies were incompatible with thehospital's inventory management program software and could not provide usabledata to track inventory movement and oximetry costs. Converting to Masimo SETpulse oximetry helped Saint Barnabas Medical Center to overcome thesechallenges, while reducing costs and creating process efficiencies that helpto improve the process of care.
In addition to Saint Barnabas's hospital-wide standardization to MasimoSET pulse oximetry, the conversion also allows Saint Barnabas clinicians toutilize Masimo Rainbow SET technology -- an upgradable noninvasive bloodconstituent monitoring platform that is capable of measuring additional bloodconstituents that previously could only be measured with invasive procedures.Masimo Rainbow SET is the first and only method to continuously andnoninvasively measure total hemoglobin (SpHb(TM)) and oxygen content(SpOC(TM)) (both pending regulatory clearances), carboxyhemoglobin (SpCO) andmethemoglobin (SpMet), in addition to oxyhemoglobin (SpO2), perfusion index(PI), pleth variability index (PVI) and pulse rate. Developed as a scalableand upgradable technology platform, Masimo Rainbow SET enables clinicians andhospitals to do more with their Masimo devices by building and expanding thenoninvasive measurements, capabilities and features within the platform. Thisallows hospitals to make an investment in patient safety today that won'tbecome obsolete tomorrow.
By making the conversion to Masimo, Saint Barnabas joins many of the tophospitals in the United States -- including four of the top five -- as listedon the US News & World Report Hon